Revance Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $15M | 6.0M | 2.57 |
| 2024-03-31 | $27M | 5.4M | 4.92 |
| 2023-12-31 | $45M | 5.1M | 8.79 |
| 2023-09-30 | $55M | 4.8M | 11.47 |
| 2023-06-30 | $118M | 4.7M | 25.31 |
| 2023-03-31 | $148M | 4.6M | 32.21 |
| 2022-12-31 | $83M | 4.5M | 18.46 |
| 2022-06-30 | $51M | 3.7M | 13.82 |
| 2022-03-31 | $71M | 3.6M | 19.50 |
| 2021-09-30 | $100M | 3.6M | 27.86 |
| 2021-06-30 | $107M | 3.6M | 29.64 |
| 2021-03-31 | $99M | 3.5M | 27.95 |
| 2020-12-31 | $92M | 3.2M | 28.34 |
| 2020-09-30 | $79M | 3.2M | 25.14 |
| 2020-06-30 | $71M | 2.9M | 24.42 |
| 2020-03-31 | $40M | 2.7M | 14.80 |
| 2019-12-31 | $41M | 2.5M | 16.23 |
| 2019-09-30 | $28M | 2.1M | 13.18 |
| 2019-03-31 | $33M | 2.1M | 15.76 |
| 2018-12-31 | $35M | 1.7M | 20.00 |
| 2018-09-30 | $37M | 1.5M | 24.85 |
| 2018-06-30 | $41M | 1.5M | 27.46 |
| 2018-03-31 | $41M | 1.3M | 30.80 |
| 2017-12-31 | $44M | 1.2M | 35.75 |
| 2017-09-30 | $28M | 1.0M | 27.73 |
| 2017-06-30 | $25M | 932k | 26.40 |
| 2017-03-31 | $18M | 868k | 20.80 |
| 2016-12-31 | $17M | 826k | 20.00 |
| 2016-09-30 | $13M | 812k | 16.22 |
| 2016-06-30 | $11M | 784k | 13.61 |
| 2015-12-31 | $22M | 653k | 34.16 |
| 2015-09-30 | $14M | 483k | 29.76 |
| 2015-06-30 | $14M | 449k | 31.97 |
| 2015-03-31 | $8.7M | 418k | 20.74 |
| 2014-12-31 | $6.5M | 384k | 16.94 |
| 2014-09-30 | $6.1M | 318k | 19.29 |
| 2014-06-30 | $7.8M | 228k | 34.06 |
| 2014-03-31 | $4.3M | 135k | 31.55 |